The Human Cancer PrimaCell™ 9: Kidney Tumor Cells is for rapid (7-10 days) isolation and growth of human Kidney tumor cells from human kidney tumor tissues. This system features an optimal condition of tissue dissociation system, Cancer OptiTDS™ that yields 6-8 times of single cells more than most of the tissue dissociation protocols published in the literature. In addition, this system ensures a high viability of the target cells with improved gradient contained in the culture medium.

Human Cancer PrimaCell™ 9 System (Cat No. 2-96032):
Human Cancer PrimaCell™ 9: Kidney Tumor Cells Protocols
Human Cancer Tissue Preparation Buffer 9: Kidney Tumor Cells
Human Cancer OptiTDS™ 9: Tissue Dissociation System
Human Cancer PrimaCell™ 9: Kidney Tumor Cells Growth Medium
Human Cancer PrimaCell™ 9: Kidney Tumor Cells Growth Supplements with Serum (for 500 ml medium)

References:

[1] Trojaneck B, Niemitz S, Micka B, Lefterova P, Blasczyk R, Scheffold C, Huhn D, Schmidt-Wolf IG. Establishment and characterization of colon carcinoma and renal cell carcinoma primary cultures. Cancer Biother Radiopharm. 2000 Apr;15(2):169-74.
[2] Uzelac-Keserović B, Spasić P, Bojanić N, Dimitrijević J, Lako B, Lepsanović Z, Kuljić-Kapulica N, Vasić D, Apostolov K. Isolation of a coronavirus from kidney biopsies of endemic Balkan nephropathy patients. Nephron. 1999 Feb;81(2):141-5.
[3] Morash BA, Lee CL, Rowden G, Riddell DC, Guernsey DL. Establishment and characterization of a renal cell carcinoma line from a patient with von Hippel-Lindau syndrome. Cancer Genet Cytogenet. 1997 Jul 1;96(1):50-7.